Alcalá PD, Siordia ZSP

Language: Spanish
References: 22
Page: 143-147
PDF size: 98.96 Kb.

ABSTRACT

Androgenetic alopecia is the most commonly occurring form of balding on the scalp. It is the progressive loss of clearly visible terminal hair, which is replaced by nearly invisible fine vellus hair in response to circulating androgens. Particularly affects men. In the women the thinning may be diffuse, but is generally greatest in the frontal/parietal region, with the frontal hairline being characteristically retained. Hair loss is therefore experienced by men and women as a detrimental event of great social and personal consequences that importantly affect them quality of life.

REFERENCES

1. Dunitz M, Randall V. The biology of androgenetic alopecia. Hair and its disorders. United King 2000: 123-136.

2. Norwood O. Incidence of female androgenetic alopecia (female patron alopecia). Dermatol Surg 2001; 27(1): 51-52.

3. Whiting D. Possible mechanism of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol 2001; 45(3): S81-S86.

4. Sprecher E, Shalata A, Dabhah K et al. Androgenetic alopecia in heterozygous carriers of a mutation in the human hairless gene. J Am Acad Dermatol 2000; 42(6): 978-982.

5. Mahé Y, Michelet J, Billoni N et al. Androgenetic alopecia and microinflammation. Int J Dermatol 2000; 39: 576-584.

6. Bayne E, Flanagan J, Einstein M et al. Immunohistochemical localization of types 1 and 2 of 5 alfa reductase in human scalp. Br J Dermatol 1999; 141: 481-491.

7. Thiboutot D, Knaggs H, Gilliland K et al. Activity of type 1 of 5 alfa reductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 1997; 136: 166-171.

8. Venning V, Dawber R. Patterned androgenetic alopecia in women. J Am Acad Dermatol 1988; 18(5): 1073-1077.

9. Olsen E. The midline part: An important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol 1999; 40(1): 106-109.

10. Ludwig E. Classification of types of androgenetic alopecia (commin baldness) ocurring in the female sex. Br J Dermatol 1977; 97: 247-254.

11. Kivanç I, Savas C, Godkdemir G et al. The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol 2003; 42: 691-693.

12. Weedon D. Alopecia androgenética. Piel Patología. España 2002: 406-407.

13. Olsen E. Female pattern hair loss. J Am Acad Dermatol 2001; 45(3): S70-S80.

14. Price V, Roberts J, Hordinsky M et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad 2000; 43: 768-776.

15. Shum K, Messenger. Hair loss in women with hyperandrogenism: Four cases responding to finasteride. J Am Acad Dermatol 2002; 47: 733-739.

16. Khandpur S, Suman M, Reddy B. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol 2002; 29: 489-498.

17. Unger W, Unger R. Hair transplantin: An important but often forgotten treatment for female pattern hair loss. J Am Acad 2003; 49: 853-860.

18. Cash T. The psychosocial consequences of androgenetic alopecia: a review of research literature. Br J Dermatol 1999; 141: 398-405.

19. Cash T. Psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992; 26: 926-931.

20. Lee H, Ha S, Kim D et al. Perception of men with androgenetic alopecia by women and nonbalding men in Korea: How the nonbald regard the bald. Int J Dermatol 2002; 41: 867-869.

21. Van der Donk J, Meulenberg D, Stolz E et al. Psychologic characteristics of men with androgenetic alopecia and their modification. Int J Dermatol 1991; 30(1): 22-28.

22. Maffei C, Fossati A, Rinaldi F et al. Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol 1994; 130: 868-872.